Siemens launches PACS non-obsolescence program

Article

Siemens launches PACS non-obsolescence programSiemens Medical Systems moved to protect its customers’ PACS networks this month when it introduced its PACS non-obsolescence program. Iselin, NJ-based Siemens expects the program to help

Siemens launches PACS non-obsolescence program

Siemens Medical Systems moved to protect its customers’ PACS networks this month when it introduced its PACS non-obsolescence program. Iselin, NJ-based Siemens expects the program to help clients upgrade hardware and software at a fixed price, allowing PACS and information technology system networks to be upgraded over their life expectancy.

Siemens’ non-obsolescence program helps customers budget for PACS upgrades, provides two weeks of product engineering consulting per year, and allows access to Siemens’ service and applications staff. The company has already signed two clients to the program in deals estimated at more than $2 million: the Cleveland Clinic has a four-year agreement, while the Children’s Medical Center of Dallas has a five-year contract.

© 2000 Miller Freeman, Inc., a United News & Media company

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.